Citigroup’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History

Citigroup’s Portfolio FWP Stock Details FWP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,187	Closed	-$19K	–	6941
2022 Q1	$19K	Buy	+3,187	New	+$17.8K	﹤0.01%	5194
2016 Q1	–	Sell	-8	Closed	-$1K	–	7946
2015 Q4	$1K	Buy	8 +4	+100%	+$642	﹤0.01%	7460
2015 Q3	$1K	Buy	+4	New	+$841	﹤0.01%	7272

Other funds holding FWP

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citigroup's FWP Position: Q2 2022 in Review

Citigroup sold out of Forward Pharma A/S American Depositary Shares (FWP) in Q2 2022, closing a stake of 3,187 shares — an estimated $19K sold.

Citigroup first reported a position in FWP in Q3 2015 and held it in 3 quarters. The position peaked at $19K in Q1 2022. 6 funds tracked by Wall St. Rank hold FWP as of Q2 2022.

Citigroup reported no remaining Forward Pharma A/S American Depositary Shares position as of Q2 2022 after selling out during the quarter.
Citigroup sold 3,187 Forward Pharma A/S American Depositary Shares shares in Q2 2022, an estimated $19K.
Citigroup first reported a position in Forward Pharma A/S American Depositary Shares in Q3 2015 and held it in 3 quarters.
Citigroup's Forward Pharma A/S American Depositary Shares position peaked at $19K in Q1 2022.
6 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q2 2022.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.